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 Abstract 
 Aims: Peripheral cannulas in newborns are commonly used 
for intravenous treatment. However sustained maintenance of 
cannula patency is often diffi cult to achieve in this age group. 
This study compares the duration for which cannula patency 
can be maintained in newborns under continuous infusion, or 
an intermittent fl ushing regimen, with normal saline. 
 Methods: A prospective observational study was conducted 
during a 12-month period. All newborns admitted to the 
16-bed intermediate care unit, who required intravenous 
treatment, received either continuous peripheral infusion with 
0.9 % saline at an infusion rate of 2 mL/h or an intravenous 
cannula, which was fl ushed with 1 mL of 0.9 % saline at least 
once every 24 h. 
 Results: A total of 53 patients with 86 cannulas were included. 
Twenty-fi ve (47 % ) patients received 41 continuous infusions. 
The intermittent fl ushing group consisted of 28 (53 % ) patients 
with 45 cannulas administered. The cannula patency was sig-
nifi cantly longer in the intermittent fl ushing group (mean 62.1 
vs. 92.8 h, P = 0.01). The patient ’ s underlying disease and the 
cannula insertion site were not related with the duration of the 
cannula patency. 
 Conclusions: Our study shows that intermittent cannula 
fl ushing is associated with improved cannula patency for 
peripherally inserted venous catheters in newborns. 
 Keywords:  Cannula patency;  continuous infusion;  intermit-
tent fl ushing;  newborns;  peripheral intravenous catheter. 
 Introduction 
 Peripheral cannulas are commonly used in newborns for the 
intravenous application of fl uids and drugs. Intravenous can-
nulation and therapy with continuous infusion may require 
the newborn to be separated from its mother and can delay 
the establishment of maternal infant bonding  [4, 9] . In new-
borns requiring drug administration, but no continuous fl uid 
therapy, intermittent use of the cannula enables intravenous 
treatment in an ambulatory setting, which prevents separa-
tion of mother and newborn and alleviates the necessity of the 
parent ’ s presence in the ward. Repeated venous access can 
be diffi cult to achieve in this patient group over time and is 
a stressful experience for the newborn, the new parents and 
the medical staff  [5, 10] . Therefore, sustained maintenance of 
cannula patency is an imperative for prolonged intravenous 
treatment. Not much information on the different means of 
maintaining intravenous cannula patency is available in the 
literature. In a Cochrane review in 2005, Flint et al. focused 
on factors that infl uence the longevity of venous peripheral 
access and compared the outcome of continuous infusion to 
that of intermittent fl ushing. They were not able to establish 
that either method was superior to the other  [1] . 
 The primary goal of the present study was to compare the 
duration of initial cannula patency under continuous infusion, 
in comparison to intermittent fl ushing with normal saline 
solution. In addition, the total number of cannulas inserted, 
the duration of total cannula patency, role of the underlying 
disease, weight and age of the newborn, as well as the cannula 
insertion site were investigated. 
 Patients and methods 
 The present prospective observational study analyzed the impact 
of two different treatment regimes on the patency of peripherally 
inserted venous cannulas in newborns. The study was conducted in 
the 16-bed neonatal intermediate care unit of a university teaching 
children ’ s hospital during a 12-month period using a convenience-
based sampling strategy. The study was approved by the local Ethical 
Committee. 
 During the fi rst 6 months of the study (July–December 2008), all 
newborns admitted to the unit who required intravenous treatment, 
received continuous peripheral infusion with 0.9 % saline, at an infu-
sion rate of 2 mL/h. During the course of the following 6 months 
(January–July 2009) all admitted newborns requiring peripheral 
injection of drugs were treated via an intravenous cannula, which 
was fl ushed with 1 mL of 0.9 % saline at least once every 24 h. If 
the newborn required antibiotics, the cannula was fl ushed with 1 mL 
saline after each drug application, respectively every 8 h. In all cases 
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a 24-gauge, 19 mm long peripheral catheter (Insyte-N BD, Becton 
Dickinson, Allschwil, Switzerland) was used with a 10 cm long sy-
ringe pump infusion line (Syramed line, Arcomed AG, Switzerland) 
and a three-way stopcock (Discofi x C-3, Braun AG, Switzerland). 
All cannulas were secured and controlled according to the hospital 
protocol, including fi xation on a splint if the cannula was inserted in 
the back of the hand, foot or crook of the elbow. For each treatment 
regimen the following measures were noted: gestational age, age at 
insertion of fi rst cannula, being born small for gestational age (SGA), 
weight of the newborn, underlying disease, date and time of cannula 
insertion, insertion site, date, time and reason of cannula removal. 
For the statistical analysis, the cannula insertion site was defi ned as 
 “ distal ” , corresponding to the back of the hand or foot vs.  “ proxi-
mal ” , corresponding to the crook of the elbow or scalp. Concerning 
the newborn ’ s underlying disease we only investigated whether or 
not sepsis was present during the investigation period. Sepsis was 
defi ned as the presence of positive blood cultures, clinical signs with 
temperature instability, mottled or pale skin, irritability and signs of 
infection in the blood sample. We focused on the infl uence of sepsis 
on cannula patency and removal, suggesting that a patient with sep-
sis and therefore bacteremia might be more susceptible to develop 
phlebitis and/or local infection at the site of foreign material in his 
blood stream. 
 Statistics 
 Statistical analysis was performed with SPSS, Version 16.0, using 
the Mann-Whitney non-parametric test for independent samples and 
multiple linear regressions for risk factor analysis with a statistical 
signifi cance defi ned by P < 0.05. 
 Results 
 During the fi rst 6-month study period, 25 patients receiving 
a total of 41 continuous infusions were included. During the 
second 6-month period, 28 patients with a total of 45 cannulas 
were included, the intravenous cannula being intermittently 
fl ushed with 0.9 % saline. Gestational age was equally dis-
tributed among the two treatment groups (P = 0.43) and 
there was no difference with regard to newborns being born 
small for gestational age (SGA) between the two treatment 
groups (intermittent fl ushing group: 1/28, continuous infu-
sion group: 2/25; P = 0.60). Gestational age and SGA showed 
no statistically signifi cant effect on duration of cannula pat-
ency when entered into the regression analysis (P = 0.32 and 
P = 0.47, respectively). There were no differences in body 
weight or time of initial cannula insertion between the two 
treatment groups (Table 1A). There were signifi cantly more 
sepsis patients in the intermittent fl ushing group (71.4 % ) than 
in the group treated with continuous infusion (40 % ; P = 0.03). 
The initial insertion of the intravenous cannula in both groups 
took place at the back of the hand (n = 31) or foot (n = 10), in 
the crook of the elbow (n = 7) or in the scalp (n = 5) and there 
was no statistically signifi cant difference between the two 
treatment groups with respect to insertion site of the initial 
cannula (P = 0.18). There was also no statistically signifi cant 
difference in the total number of employed cannulas between 
the treatment groups (P = 0.51). Inserted cannulas were 
removed for reasons of infi ltration/extravasation, occlusion, 
phlebitis or because they were no longer required. There was 
no difference in reasons for loss of function for the initially 
inserted cannulas between the treatment groups (P = 0.11). In 
the continuous infusion group the reasons for loss of cannula 
function were distributed as follows: 14 (56 % ) infi ltration, 3 
(12 % ) phlebitis, 2 (8 % ) occlusion and 6 (24 % ) intact can-
nula removal, because it was no longer required. The corre-
sponding fi gures for the intermittent fl ushing group were: 12 
(42.9 % ) infi ltration, 2 (7.1 % ) occlusion and 14 (50 % ) intact 
cannula removal, because it was no longer required. 
 The cannulas employed in the intermittent fl ushing group 
retained their patency for a signifi cantly longer period than 
did those employed in the continuous infusion group, with 
respect to both the initially inserted and the total number of 
 Table 1A  Demographic data and main results for the initial cannula per patient. 
Treatment group P-value
Continuous infusion (n = 25) Intermittent fl ushing (n = 28)
Patient weight in g (mean ± SD) 3375 ± 814 3435 ± 588 0.85
Patient age at fi rst cannula in days (mean ± SD) 12.1 ± 9.5 14.5 ± 8.2 0.28
Cannula insertion site 0.18
 Distal site (n/ % ) 21/84 27/96.4
 Proximal site (n/ % ) 4/16 1/3.6
Sepsis (n/ % ) 10/40.0 19/71.4 0.03
Cannula patency in hours (mean ± SD) 62.1 ± 44.3 92.8 ± 55.7 0.01
 Table 1B  Main results for the total of cannulas per patient. 
Treatment group P-value
Continuous infusion (n = 41) Intermittent fl ushing (n = 45)
Sepsis (n/ % ) 19/46.3 33/75.0 0.016
Cannula patency in hours (mean ± SD) 53.9 ± 38.0 85.4 ± 56.5 0.002
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 Figure 1  Kaplan-Meier survival curve for duration of cannula pat-
ency in hours. 
cannulas per individual patient (P = 0.01 and P = 0.002, respec-
tively: Tables  1A and  1B ). The Kaplan-Meier curve depicts 
the statistically signifi cant difference in the duration of can-
nula patency between the two treatment regimens (log rank 
test 0.032: Figure  1 ). Cannula insertion site, gestational age, 
being born SGA, age and weight of the newborn, had no 
effect on the longevity of cannula patency (P = 0.44, P = 0.32, 
P = 0.47, P = 0.51 and P = 0.46, respectively). Sepsis did not 
infl uence the duration of cannula patency (P = 0.37). 
 Discussion 
 The aim of the present study was to compare the duration 
of peripheral venous cannula patency in newborns under two 
different conditions (continuous infusion vs. intermittent 
fl ushing). We could demonstrate that patency was retained for 
a signifi cantly longer duration upon intermittent fl ushing than 
upon continuous infusion. This increased longevity applied to 
both the initially inserted cannula as well as to the total num-
ber of applied cannulas per individual newborn. 
 A Cochrane review published by Flint et al. in 2005 
included the only two controlled randomized trials compar-
ing continuous infusion with intermittent fl ushing, in order 
to prevent loss of function of peripheral intravenous cannu-
las in newborns requiring drug administration  [1] . One of the 
included studies describes similar duration of cannula pat-
ency in both treatment groups for the fi rst cannula used per 
newborn. However, almost twice as many cannulas were used 
in the continuous infusion group compared to the intermittent 
fl ushing group  [2] . In the second randomized trial, patency 
duration of the fi rst cannula used per infant was not reported. 
The duration of cannula patency was, in accordance with 
our fi ndings, signifi cantly longer in the intermittent fl ushing 
group (P-value = 0.0003), for all catheters averaged during the 
treatment course. The mean number of catheters used, defi ned 
for the fi rst 48 h of treatment, was signifi cantly higher in the 
continuous infusion group  [8] . In conclusion, the data of the 
Cochrane review were not able to establish that either method 
was superior to the other  [1] , but the results support the use of 
intermittent fl ushing with saline 0.9 % in newborns requiring 
drug administration. This is in accordance with our fi ndings. 
 Similar results were also reported in a retrospective cohort 
study conducted in 2003. Flint et al. compared the duration of 
cannula patency for continuous infusion vs. intermittent fl ush-
ing in term newborns requiring intravenous medication only. 
Their study design was very similar to ours even though the 
fl ushing interval was shorter than in our study (6 h vs. 8 – 24 h, 
respectively). The study demonstrated that intravenous can-
nulas last just as long if they are fl ushed intermittently with 
sodium chloride and do not have a continuous infusion run-
ning. After the intermittent fl ushing regimen was established, 
the authors report the observation of various benefi ts includ-
ing easy access for mothers to initiate early feeding, greater 
involvement of parents in infant care, potential cost savings, 
and enhanced maternal-infant bonding. 
 In our study, the reasons for loss of function for the fi rst 
cannula used per newborn were similarly distributed between 
the two treatment groups. This is in contrast to the fi ndings 
of both studies included in the Cochrane review. Kalyn et al. 
report a statistically signifi cant difference (P-value  < 0.001): 
in the intermittent fl ushing group catheters were less likely to 
infi ltrate, leak or develop phlebitis whereas in the continuous 
infusion group they were less likely to occlude  [2] . Taylor et 
al.  [8] focus on extravasation, defi ned as the number of infi l-
trations per day. They report the mean of infi ltrations a day to 
be signifi cantly higher in the continuous infusion group com-
pared to the intermittent fl ushing group (P-value = 0.0015). 
 When we analyzed the newborns ’ underlying disease in 
our study, there were signifi cantly more sepsis patients in the 
intermittent fl ushing group compared to the continuous infu-
sion group. However, no difference was shown in the reasons 
for loss of cannula function for the fi rst cannula used per new-
born between the two treatment groups. Furthermore, sepsis 
did not infl uence the duration of cannula patency. 
 A number of trials have investigated the role of heparin 
in peripheral venous catheters of the newborn  [3, 6, 7] . No 
heparin was used in either of our treatment groups, thus this 
was no object of investigation. 
 One limitation to our study is that we investigated two dif-
ferent treatment methods in two separate time periods, which 
could possibly lead to a bias due to unrecognized temporal 
changes on our intermediate neonatal care unit. However, 
even if subtle changes over time cannot be completely 
excluded, there were certainly no major shifts in staff and/or 
treatment policies on the unit during the 12-month period of 
investigation. 
 The conclusion which can be drawn from the results of our 
study and with respect to previously published data  [1, 2] in 
the literature is the following: intermittent cannula fl ushing 
may be associated with increased duration of cannula pat-
ency for peripherally inserted venous catheters in newborns. 
This application modus has not shown any disadvantages and 
potentially allows intravenous treatment in an ambulatory 
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setting. The current data support the use of intermittent fl ush-
ing of cannulas in selected populations of neonatal nurser-
ies requiring drug administration only. However, in order to 
establish a new gold standard of care for peripheral venous 
cannulation in newborns, adequately powered randomized 
controlled trials will be needed. 
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